{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:18:48Z","timestamp":1793971128274,"version":"4.8.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inherited metabolic disorders (IMDs) in neonates are a diagnostic and therapeutic challenge for the neonatologist, with the priority being to rapidly flag the treatable diseases. The objective of this study was to evaluate the contribution of targeted metabolic testing for diagnosing suspected IMDs on the basis of suggestive clinical setting or family history in neonates. We conducted an observational study over five years, from January 1st, 2010 to December 31, 2014 in the neonatal intensive care unit (NICU) at Robert Debr\u00e9 University Hospital, Paris, France. We assessed the number of neonates for whom a metabolic testing was performed, the indication for each metabolic test and the diagnostic yield of this selected metabolic workup for diagnosing an IMD. Metabolic testing comprised at least one of the following testings: plasma, urine or cerebrospinal fluid amino acids, urine organic acids, plasma acylcarnitine profile, and urine mucopolysaccharides and oligosaccharides. 11,301 neonates were admitted at the neonatal ICU during the study period. One hundred and ninety six neonates underwent metabolic testing. Eleven cases of IMDs were diagnosed. This diagnostic approach allowed the diagnosis, treatment and survival of 4 neonates (maple syrup urine disease, propionic acidemia, carnitine-acylcarnitine translocase deficiency and type 1 tyrosinemia). In total, metabolic testing was performed for 1.7% of the total number of neonates admitted in the NICU over the study period. These included 23% finally unaffected neonates with transient abnormalities, 5.6% neonates suffering from an identified IMD, 45.4% neonates suffering from a non-metabolic identified disease and 26% neonates with chronic abnormalities but for whom no final causal diagnosis could be made. In conclusion, as expected, such a metabolic targeted workup allowed the diagnosis of classical neonatal onset IMDs in symptomatic newborns. However, this workup remained normal or unspecific for 94.4% of the tested patients. It allowed excluding an IMD in 68.4% of the tested neonates. In spite of the high rate of normal results, such a strategy seems acceptable due to the severity of the symptoms and the need for immediate treatment when available in neonatal IMDs. However, its cost-effectiveness remains low especially in a clinically targeted population in a country where newborn screening is still unavailable for IMDs except for phenylketonuria in 2019.<\/jats:p>","DOI":"10.1038\/s41598-019-50518-0","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T06:02:32Z","timestamp":1569909752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening"],"prefix":"10.1038","volume":"9","author":[{"given":"Alexandra","family":"Bower","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Imbard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Benoist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Rigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8272-232X","authenticated-orcid":false,"given":"Manuel","family":"Schiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"issue":"i\u2013iv","key":"50518_CR1","first-page":"1","volume":"1","author":"CA Seymour","year":"1997","unstructured":"Seymour, C. A. et al. Newborn screening for inborn errors of metabolism: a systematic review. Health Technol. Assess. Winch. Engl. 1(i\u2013iv), 1\u201395 (1997).","journal-title":"Health Technol. Assess. Winch. Engl."},{"key":"50518_CR2","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1542\/peds.105.1.e10","volume":"105","author":"DA Applegarth","year":"2000","unstructured":"Applegarth, D. A. & Toone, J. R. & others. Incidence of inborn errors of metabolism in British Columbia, 1969\u20131996. Pediatrics 105, e10\u2013e10 (2000).","journal-title":"Pediatrics"},{"key":"50518_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1442-200X.2010.03177.x","volume":"53","author":"ML Couce","year":"2011","unstructured":"Couce, M. L. et al. Inborn errors of metabolism in a neonatology unit: Impact and long-term results: Neonatal inborn errors of metabolism. Pediatr. Int. 53, 13\u201317 (2011).","journal-title":"Pediatr. Int."},{"key":"50518_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-017-0247-4","volume":"10","author":"JM Friedman","year":"2017","unstructured":"Friedman, J. M. et al. Genomic newborn screening: public health policy considerations and recommendations. BMC Med. Genomics 10, 9 (2017).","journal-title":"BMC Med. Genomics"},{"key":"50518_CR5","doi-asserted-by":"publisher","first-page":"e0156359","DOI":"10.1371\/journal.pone.0156359","volume":"11","author":"D Yubero","year":"2016","unstructured":"Yubero, D. et al. Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism. PloS One 11, e0156359 (2016).","journal-title":"PloS One"},{"key":"50518_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000443874","volume":"109","author":"WJ van Rijt","year":"2016","unstructured":"van Rijt, W. J. et al. Inborn Errors of Metabolism That Cause Sudden Infant Death: A Systematic Review with Implications for Population Neonatal Screening Programmes. Neonatology 109, 297\u2013302 (2016).","journal-title":"Neonatology"},{"key":"50518_CR7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","volume":"32","author":"R Guthrie","year":"1963","unstructured":"Guthrie, R. & Susi, A. A Simple Phenylalanine Method For Detecting Phenylketonuria in Large Populations of Newborn Infants. Pediatrics 32, 338\u2013343 (1963).","journal-title":"Pediatrics"},{"key":"50518_CR8","unstructured":"Inborn metabolic diseases: diagnosis and treatment. (Springer, 2012)."},{"key":"50518_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1080\/14767050903181500","volume":"22","author":"L Atzori","year":"2009","unstructured":"Atzori, L., Antonucci, R., Barberini, L., Griffin, J. L. & Fanos, V. Metabolomics: a new tool for the neonatologist. J. Matern. Fetal Neonatal Med. 22, 50\u201353 (2009).","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"50518_CR10","first-page":"953","volume":"19","author":"F Labarthe","year":"2012","unstructured":"Labarthe, F., Tardieu, M., de Parscau, L. & Lamireau, D. Clinical presentation of inborn metabolic diseases in the neonatal period. Arch. Pediatr. Organe Off. Soc. Francaise Pediatr. 19, 953\u2013958 (2012).","journal-title":"Arch. Pediatr. Organe Off. Soc. Francaise Pediatr."},{"key":"50518_CR11","doi-asserted-by":"publisher","first-page":"H156","DOI":"10.1016\/S0929-693X(12)71189-2","volume":"19","author":"D Lamireau","year":"2012","unstructured":"Lamireau, D., Benoist, J.-F. & Labarthe, F. Maladies m\u00e9taboliques en p\u00e9riode n\u00e9onatale: Quand y penser? Arch. P\u00e9diatrie 19, H156\u2013H158 (2012).","journal-title":"P\u00e9diatrie"},{"key":"50518_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1051\/medsci\/2005215512","volume":"21","author":"D Ricquier","year":"2005","unstructured":"Ricquier, D. Maladies h\u00e9r\u00e9ditaires du m\u00e9tabolisme et apports de la m\u00e9tabolomique. m\u00e9decine\/sciences 21, 512\u2013516 (2005).","journal-title":"m\u00e9decine\/sciences"},{"key":"50518_CR13","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1515\/CCLM.2003.248","volume":"41","author":"O Boulat","year":"2003","unstructured":"Boulat, O., Gradwohl, M., Matos, V., Guignard, J.-P. & Bachmann, C. Organic acids in the second morning urine in a healthy Swiss paediatric population. Clin. Chem. Lab. Med. 41, 1642\u20131658 (2003).","journal-title":"Clin. Chem. Lab. Med."},{"key":"50518_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1084-2756(03)00066-6","volume":"8","author":"S Beath","year":"2003","unstructured":"Beath, S. Hepatic function and physiology in the newborn. Semin. Neonatol. 8, 337\u2013346 (2003).","journal-title":"Semin. Neonatol."},{"key":"50518_CR15","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1542\/peds.2010-0943","volume":"126","author":"JL Slaughter","year":"2010","unstructured":"Slaughter, J. L. et al. The Effects of Gestational Age and Birth Weight on False-Positive Newborn-Screening Rates. PEDIATRICS 126, 910\u2013916 (2010).","journal-title":"PEDIATRICS"},{"key":"50518_CR16","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1542\/peds.2005-2026","volume":"118","author":"BA Tarini","year":"2006","unstructured":"Tarini, B. A., Christakis, D. A. & Welch, H. G. State Newborn Screening in the Tandem Mass Spectrometry Era: More Tests, More False-Positive Results. Pediatrics 118, 448\u2013456 (2006).","journal-title":"Pediatrics"},{"key":"50518_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/siny.2001.0083","volume":"7","author":"JM Saudubray","year":"2002","unstructured":"Saudubray, J. M., Nassogne, M. C., de Lonlay, P. & Touati, G. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin. Neonatol. 7, 3\u201315 (2002).","journal-title":"Semin. Neonatol."},{"key":"50518_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0009-8981(02)00182-1","volume":"323","author":"KG Sim","year":"2002","unstructured":"Sim, K. G., Hammond, J. & Wilcken, B. Strategies for the diagnosis of mitochondrial fatty acid \u03b2-oxidation disorders. Clin. Chim. Acta 323, 37\u201358 (2002).","journal-title":"Clin. Chim. Acta"},{"key":"50518_CR19","doi-asserted-by":"publisher","first-page":"H159","DOI":"10.1016\/S0929-693X(12)71190-9","volume":"19","author":"J-F Benoist","year":"2012","unstructured":"Benoist, J.-F., Lamireau, D. & Labarthe, F. Maladies m\u00e9taboliques en p\u00e9riode n\u00e9onatale: enqu\u00eate biochimique. Arch. P\u00e9diatrie 19, H159\u2013H160 (2012).","journal-title":"Arch. P\u00e9diatrie"},{"key":"50518_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/gim.2013.171","volume":"16","author":"M Morris","year":"2014","unstructured":"Morris, M. et al. Reduction in newborn screening metabolic false-positive results following a new collection protocol. Genet. Med. 16, 477\u2013483 (2014).","journal-title":"Genet. Med."},{"key":"50518_CR21","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/j.clinbiochem.2013.08.009","volume":"46","author":"PE Karam","year":"2013","unstructured":"Karam, P. E. et al. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: A twelve-year experience. Clin. Biochem. 46, 1787\u20131792 (2013).","journal-title":"Clin. Biochem."},{"key":"50518_CR22","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics Committee on Fetus And Newborn & American College of Obstetricians and Gynecologists Committee on Obstetric Practice. The Apgar Score. Pediatrics 136, 819\u2013822 (2015).","DOI":"10.1542\/peds.2015-2651"},{"key":"50518_CR23","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1007\/s00431-015-2540-6","volume":"174","author":"R Hegarty","year":"2015","unstructured":"Hegarty, R., Hadzic, N., Gissen, P. & Dhawan, A. Inherited metabolic disorders presenting as acute liver failure in newborns and young children: King\u2019s College Hospital experience. Eur. J. Pediatr. 174, 1387\u20131392 (2015).","journal-title":"Eur. J. Pediatr."},{"key":"50518_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/0140-6736(93)91809-Z","volume":"342","author":"J Bernuau","year":"1993","unstructured":"Bernuau, J. & Benhamou, J. P. Classifying acute liver failure. Lancet Lond. Engl. 342, 252\u2013253 (1993).","journal-title":"Lancet Lond. Engl."},{"key":"50518_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ppedcard.2007.08.013","volume":"24","author":"GF Cox","year":"2007","unstructured":"Cox, G. F. Diagnostic Approaches to Pediatric Cardiomyopathy of Metabolic Genetic Etiologies and Their Relation to Therapy. Prog. Pediatr. Cardiol. 24, 15\u201325 (2007).","journal-title":"Prog. Pediatr. Cardiol."},{"key":"50518_CR26","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s10545-012-9569-8","volume":"33","author":"SN Garcia","year":"2010","unstructured":"Garcia, S. N. et al. Maternal and fetal tyrosinemia type I. J. Inherit. Metab. Dis. 33, 507\u2013510 (2010).","journal-title":"J. Inherit. Metab. Dis."},{"key":"50518_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-8","volume":"8","author":"C de Laet","year":"2013","unstructured":"de Laet, C. et al. Recommendations for the management of tyrosinaemia type 1. Orphanet J. Rare Dis. 8, 8 (2013).","journal-title":"Orphanet J. Rare Dis."},{"key":"50518_CR28","doi-asserted-by":"crossref","unstructured":"Chalmers, R. A. & Lawson, A. M. Organic acids in man: analytical chemistry, biochemistry, and diagnosis of the organic acidurias. (London; New York: Chapman and Hall 1982).","DOI":"10.1007\/978-94-009-5778-7"},{"key":"50518_CR29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/clinchem\/47.11.1945","volume":"47","author":"TH Zytkovicz","year":"2001","unstructured":"Zytkovicz, T. H. et al. Tandem Mass Spectrometric Analysis for Amino, Organic, and Fatty Acid Disorders in Newborn Dried Blood Spots. Clin. Chem. 47, 1945\u20131955 (2001).","journal-title":"Clin. Chem."},{"key":"50518_CR30","unstructured":"Berg, J. S. et al. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics 139 (2017)."},{"key":"50518_CR31","first-page":"214","volume":"18","author":"SF Kingsmore","year":"2016","unstructured":"Kingsmore, S. F. Newborn testing and screening by whole-genome sequencing. Genet. Med. Off. J. Am. Coll. Med. Genet. 18, 214\u2013216 (2016).","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"50518_CR32","doi-asserted-by":"publisher","first-page":"a023168","DOI":"10.1101\/cshperspect.a023168","volume":"6","author":"LD Smith","year":"2015","unstructured":"Smith, L. D., Willig, L. K. & Kingsmore, S. F. Whole-Exome Sequencing and Whole-Genome Sequencing in Critically Ill Neonates Suspected to Have Single-Gene Disorders. Cold Spring Harb. Perspect. Med. 6, a023168 (2015).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"50518_CR33","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamapediatrics.2017.1755","volume":"171","author":"TY Tan","year":"2017","unstructured":"Tan, T. Y. et al. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions. JAMA Pediatr. 171, 855\u2013862 (2017).","journal-title":"JAMA Pediatr."},{"key":"50518_CR34","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapediatrics.2017.1970","volume":"171","author":"JR Lemke","year":"2017","unstructured":"Lemke, J. R. High-Throughput Sequencing as First-Tier Diagnostics in Congenital and Early-Onset Disorders. JAMA Pediatr. 171, 833\u2013835 (2017).","journal-title":"JAMA Pediatr."},{"key":"50518_CR35","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamapediatrics.2017.1743","volume":"171","author":"AT Berg","year":"2017","unstructured":"Berg, A. T. et al. Early-Life Epilepsies and the Emerging Role of Genetic Testing. JAMA Pediatr. 171, 863\u2013871 (2017).","journal-title":"JAMA Pediatr."},{"key":"50518_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/ana.21435","volume":"64","author":"HM Engbers","year":"2008","unstructured":"Engbers, H. M. et al. Yield of additional metabolic studies in neurodevelopmental disorders. Ann Neurol. 64, 212\u20137 (2008).","journal-title":"Ann Neurol."},{"key":"50518_CR37","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ymgme.2014.01.011","volume":"111","author":"CD Van Karnebeek","year":"2014","unstructured":"Van Karnebeek, C. D. et al. The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource. Mol Genet Metab. 111, 428\u201338 (2014).","journal-title":"Mol Genet Metab."},{"key":"50518_CR38","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3349\/ymj.2018.59.5.652","volume":"59","author":"JM Ko","year":"2018","unstructured":"Ko, J. M. et al. A New Integrated Newborn Screening Workflow Can Provide a Shortcut to Differential Diagnosis and Confirmation of Inherited Metabolic Diseases. Yonsei Med J. 59, 652\u2013661 (2018).","journal-title":"Yonsei Med J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50518-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50518-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T09:10:13Z","timestamp":1671268213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-50518-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["50518"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-50518-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,1]]},"assertion":[{"value":"2 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14098"}}